CD28 signaling domain boosts persistence and in vivo anti-tumor activity of stem cell-derived CD19-CAR-NK cells
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1016/j.isci.2025.112548
dc.identifier.other
WOS:001496973900001
dc.description.volume
dc.description.issue
Publisher
CELL PRESS
DOI
10.1016/j.isci.2025.112548